European Registry on the Management of Helicobacter Pylori Infection
Latest Information Update: 08 Oct 2024
At a glance
- Drugs Tripotassium dicitrato bismuthate/tetracycline/metronidazole (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- Acronyms Hp-EuReg
- 02 Oct 2024 Planned End Date changed from 1 Dec 2024 to 1 Dec 2034.
- 02 Oct 2024 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2034.
- 05 Dec 2022 Results (n=2144) reporting eight-year experience in patients from the European Registry using data collected and quality reviewed until Oct 2021 at Asociacion Espanola de Gastroenterologia-Research Electronic Data Capture published in the Gut